Evidence map›Paper›PMID 20304061›Full record

ReviewThe Journal of steroid biochemistry and molecular biology2010

Vitamin D and diabetes.

Anastassios G Pittas, Bess Dawson-Hughes

Registry-linked trialAbstract readReview
In one paragraph

Review in The Journal of steroid biochemistry and molecular biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01141192 (The Effect of Vitamin D Supplementation on Glucose Metabolism in Non-Diabetic African American Adults), which is not on this map. Cited by 67 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 2 pooled it
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01141192 nacompletednot on this map

The Effect of Vitamin D Supplementation on Glucose Metabolism in Non-Diabetic African American Adults

TypeinterventionalSponsorAugusta UniversityRan2010 to 2010Enrolled48ConditionsType 2 DiabetesArmsvitamin D3, cholecalciferol, Inactive comparator
3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 2 syntheses or guidelines pooled it, 169 citations in OpenAlex.

  1. Pooled it
  2. Vitamin D and Beta Cells in Type 1 Diabetes: A Systematic Review.International journal of molecular sciences · 2022
    Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Review
  9. Article
  10. Effective counseling for children's bone health.Journal of the Pediatric Orthopaedic Society of North America · 2024
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Anastassios G PittasDivision of Endocrinology, Diabetes and Metabolism, Tufts Medical Center, Boston, MA 02111, United States. apittas@tuftsmedicalcenter.org
Bess Dawson-Hughes
Tufts Medical Center · US

Funding

Vitamin D and Calcium Homeostasis in Relation to Type 2 DiabetesR01DK076092 · NIDDK · TUFTS MEDICAL CENTER · PI PITTAS, ANASTASSIOS G · 2006 to 2015
$4.1M
Vitamin D Status in Relation to Incident Type 2 Diabetes and Cardiometabolic RiskR01DK079003 · NIDDK · TUFTS MEDICAL CENTER · PI PITTAS, ANASTASSIOS G · 2008 to 2010
$957k
Vitamin D Status and Incident Type 2 DiabetesR21DK078867 · NIDDK · TUFTS MEDICAL CENTER · PI PITTAS, ANASTASSIOS G · 2007 to 2008
$500k
NIDDK NIH HHS R01 DK076092NIDDK NIH HHS R01 DK079003NIDDK NIH HHS R01DK76092NIDDK NIH HHS R01DK79003NIDDK NIH HHS R21 DK078867NIDDK NIH HHS R21DK78867
6 · The paper itself

Abstract

On the basis of evidence from animal and human studies, vitamin D has emerged as a potential risk modifier for type 1 and type 2 diabetes (type 1 diabetes and type 2 diabetes). Vitamin D is thought to have both direct (through activation of the vitamin D receptor) and indirect (via regulation of calcium homeostasis) effects on various mechanisms related to the pathophysiology of both types of diabetes, including pancreatic beta-cell dysfunction, impaired insulin action and systemic inflammation. Observational case-control studies have shown that vitamin D supplementation in pregnancy or early childhood is associated with reduced risk of incident type 1 diabetes. There are no trials on the effect of vitamin D (ergocalciferol or cholecalciferol) on type 1 diabetes. An association between vitamin D insufficiency and incident type 2 diabetes has been reported in longitudinal observational studies, but the association is not consistent. Results from small underpowered trials and post-hoc analyses of data from larger trials designed for bone-specific outcomes show no effect of vitamin D supplementation on glycemia in healthy adults but vitamin D may retard the progression to diabetes in adults with glucose intolerance. Because vitamin D is an excellent marker of general health status, the positive results reported in some observational studies might reflect unmeasured and unaccounted confounding. Therefore, the hypothesis that vitamin D may modify diabetes risk needs to be confirmed in trials specifically designed for that purpose.

Indexed as

Gene Expression RegulationClinical Trials as TopicDiabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2FemaleGlucoseHumansInsulinMaleModels, BiologicalPregnancyRandomized Controlled Trials as TopicResearch DesignVitamin DGlucoseInsulinVitamin D

Identifiers

PMID20304061
PMCPMC2900448
OpenAlexW2000824505

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.